Two new patents for Implanet

Implanet, a medical technology company specializing in vertebral and knee-surgery implants, said the US Patent and Trademark Office (USPTO) granted two new patents for its Jazz platform.

Implanet said the patents further strengthen its portfolio of 22 patents covering all the aspects of the Jazz platform.

Implanet CEO Ludovic Lastennet said: “Obtaining these patents is an integral part of our value-creation strategy — we aim to put solid barriers in place in an addressable spine market estimated at $2.1 billion.

“The systematic growth of our IP protection enables us to reinforce our current commercial partnerships and look towards future strategic alliances.”